About Ace Animals
Ace Animals is a Healthcare company based in United States founded in 1973, and was acquired by Sigma Aldrich in March 2010. It operates as a research rodents are bred and supplied to the biomedical sector. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Animal Models. Its competitors include Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Champion Oncology and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
Ace Animals was established in 1973 in Berkshire County, United States, as a supplier of rodents for biomedical research. Breeding services are offered for strains including Swiss Websters, Balbc, and C57BL mice, as well as Sprague Dawley rats, NIH athymic nude mice, and cotton rats. Operations focus on laboratory testing needs within the biomedical industry, with rodents provided to support scientific studies.
- Headquarters Berkshire County, United States
- Stage Acquired
- SectorsHealthcare
- Website aceanimals.com
- Acquired by Sigma Aldrich (Mar 2010)
- Investors
- Acquired bySigma Aldrich
(Mar 2010)
Investors in Ace Animals
Ace Animals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sigma Aldrich.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biochemical and organic chemicals are developed for scientific research applications. | 1951 | sigmaaldrich.com | St. Louis, United States |
Investor details for Ace Animals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ace Animals
2 dated milestones of Ace Animals across 37 years, from founding to its latest funding, stage changes and deals.
- Founded Ace Animals is founded.
- Exit Acquired by Sigma Aldrich.
Competitors of Ace Animals
Ace Animals has 9 listed competitors in our database, 7 of them funded. They include Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Champion Oncology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biocytogen.com | 2008 | Wakefield, United States | $301.11M | 85 | Integrated solutions for next-generation antibody drug development are provided. | |
| interiusbio.com | 2020 | Philadelphia, United States | $129.03M | 25 | Developer of gene therapies for treating multiple diseases | |
| appliedstemcell.com | 2008 | Milpitas, United States | $67.52M | 53 | Provider of animal and cell line models as tools for drug discovery and diagnostics | |
| genoway.com | 1999 | Lyon, France | $11.55M | – | Provider of transgenic rodent models and customized cell lines for preclinical development | |
| championsoncology.com | 1985 | Hackensack, United States | – | 230 | Drug response assays are performed using murine in vivo models. | |
| carcinotech.co.uk | 2018 | Edinburgh, United Kingdom | $7.35M | 1 | Provides 3D tumor models and assays for cancer research and preclinical testing services. | |
| invivobiosystems.com | 2019 | United States | $8.16M | – | Animal models are supplied for in-vivo analytical services. | |
| cyagen.com | 2005 | Santa Clara, United States | $40.51M | – | Contract research organization for cell culture product and animal model manufacturer | |
| janvier-labs.com | 1960 | Loire, France | – | – | Animal models for research are supplied with high genetic stability. |
Detailed competitors of Ace Animals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Ace Animals (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ace Animals
Ace Animals was founded in 1973.
Ace Animals is headquartered in United States. It is registered at Massachusetts, United States.
Ace Animals was established in 1973 in Berkshire County, United States, as a supplier of rodents for biomedical research. Breeding services are offered for strains including Swiss Websters, Balbc, and C57BL mice, as well as Sprague Dawley rats, NIH athymic nude mice, and cotton rats. Operations focus on laboratory testing needs within the biomedical industry, with rodents provided to support scientific studies.
Ace Animals's top competitors include Biocytogen, Applied StemCell and GenOway.
Ace Animals has 1 investor. Key investors include Sigma Aldrich.
Yes. Ace Animals was acquired by Sigma Aldrich in March 2010.